In clinical studies and real-world use, patients frequently report: Nausea Diarrhea Vomiting These symptoms are often most noticeable when starting the medication or increasing the dose
Eli Lilly, the pharmaceutical company developing retatrutide, has progressed the compound into Phase 3 clinical trials, which are evaluating its efficacy and safety in larger populations across multiple indications, including obesity and type 2 diabetes
Telehealth platforms like ours offer a more streamlined experience
When youre in a deficit, your body turns to stored fat for energy, which leads to weight loss
Tirzepatide Tirzepatide, a novel dual agonist of GIP and GLP-1 receptors, has demonstrated exceptional efficacy in improving glycemic control and promoting weight loss in individuals with Type 2 diabetes mellitus (T2DM) and obesity (43)
Other presentations, including Wegovy single-dose pens and many Mounjaro or Zepbound single-dose devices, cannot be click-counted at all